Panbela announces 1-for-40 reverse stock split effective january 13, 2023

Minneapolis, jan. 12, 2023 (globe newswire) --  -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will implement the previously announced and stockholder approved 1-for-40 reverse split of its common stock. the reverse stock split will be effective as of the morning of january 13, 2023, and the company's common stock will trade on a post-split basis at the beginning of trading on the same date under the existing trading symbol “pbla.” the cusip number for the common stock following the reverse stock split will be 69833w206.
PBLA Ratings Summary
PBLA Quant Ranking